←
toma tebaldi45 posts
toma tebaldi avatar

toma tebaldi

@tomalistar
◷ Joined August 2011▧ 1 Photos and videos
ANSA Trentino-AA avatar
⟳ toma tebaldi retweeted
ANSA Trentino-AA@AnsaTrentinoAA·29 Aug 2025

Leucemia pediatrica acuta, studio individua possibile terapia. Da Università Trento e Yale, per forma che colpisce bimbi Down #ANSA ow.ly/192h106kf8n

Qian Cheng avatar
⟳ toma tebaldi retweeted
Qian Cheng@sgqcheng·7 Jul 2025

Cell Marker Accordion is a user-friendly platform providing robust automatic cell annotation of #single_cell and spatial populations @RDDS_Lab #BiotechNatureComms doi.org/10.1038/s41467-025-6…

RDDS-Lab avatar
⟳ toma tebaldi retweeted
RDDS-Lab@RDDS_Lab·20 May 2025

Have you ever wondered about the “Computational limitations and future needs to unravel the full potential of 2'-O-Methylation and C/D box snoRNAs”? doi.org/10.1080/15476286.202… Congrats to @chriram97 , @EPerenthaler, Fabio Lauria, @tomalistar, Gabriella Viero

toma tebaldi avatar
toma tebaldi@tomalistar·9 Nov 2023

Please contact us if you are interested and you need more information

A two-year postdoc fellowship is available in the Laboratory of RNA & Disease Data Science: a project funded by @AIRC_it to study #cancer with advanced methods with a high-resolution investigation. 📅 Deadline: December, 4th ℹ️ rdds.it 📩toma.tebaldi@unitn.it

Post attachment
Ranjit Bindra,MD/PhD avatar
⟳ toma tebaldi retweeted
Ranjit Bindra,MD/PhD@ranjitbindra·11 Mar 2022

Bench-to-Bedside at the speed of Yale Science, very much enjoyed the collaboration with the @Halene_lab and we now are testing this concept in the clinic! Excellent team effort @Rana_Gbyli et al! @YaleCancer @YaleRadOnc @YaleOCR clinicaltrials.gov/ct2/show/…

We are very excited that our recent collaborative work with the Bindra lab @ranjitbindra is now online in @Leukemia!! "In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2"👇 1/2

Halene Lab avatar
⟳ toma tebaldi retweeted
Halene Lab@Halene_lab·11 Mar 2022

We are very excited that our recent collaborative work with the Bindra lab @ranjitbindra is now online in @Leukemia!! "In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2"👇 1/2

Beyond excited to share that our paper has been published today in @LeukemiaJnl ! Here we report the results of a rigorous in vivo pre-clinical evaluation of the PARP inhibitor, olaparib, in IDH1/2-mutant MDS/AML. nature.com/articles/s41375-0…

Yuanbin Song M.D avatar
⟳ toma tebaldi retweeted
Yuanbin Song M.D@Dr_YuanbinSong·6 Mar 2021

Thanks all the lab members in the @Halene_lab and collaborators, without their help this work will not be done! Thanks Dr.Halene,Dr. Flavell @FlavellLab for the great mentorship and outstanding guidance for this project! Thanks Dr.Shan @LShanlab for all the help and guidances!

Go #RBCs! We are so excited about modeling #erythropoiesis from stem to red cell in the @FlavellLab /Halene/@LShanlab labs’ liver-cytokine humanized mice. A sophisticated model to develop and test new treatments for #blooddiseases👇 @Dr_YuanbinSong @Rana_Gbyli @YaleHematology